Reproducibility of Differential Proteomic Technologies in CPTAC Fractionated Xenografts

[Image: see text] The NCI Clinical Proteomic Tumor Analysis Consortium (CPTAC) employed a pair of reference xenograft proteomes for initial platform validation and ongoing quality control of its data collection for The Cancer Genome Atlas (TCGA) tumors. These two xenografts, representing basal and l...

Descripción completa

Detalles Bibliográficos
Autores principales: Tabb, David L., Wang, Xia, Carr, Steven A., Clauser, Karl R., Mertins, Philipp, Chambers, Matthew C., Holman, Jerry D., Wang, Jing, Zhang, Bing, Zimmerman, Lisa J., Chen, Xian, Gunawardena, Harsha P., Davies, Sherri R., Ellis, Matthew J. C., Li, Shunqiang, Townsend, R. Reid, Boja, Emily S., Ketchum, Karen A., Kinsinger, Christopher R., Mesri, Mehdi, Rodriguez, Henry, Liu, Tao, Kim, Sangtae, McDermott, Jason E., Payne, Samuel H., Petyuk, Vladislav A., Rodland, Karin D., Smith, Richard D., Yang, Feng, Chan, Daniel W., Zhang, Bai, Zhang, Hui, Zhang, Zhen, Zhou, Jian-Ying, Liebler, Daniel C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2015
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4779376/
https://www.ncbi.nlm.nih.gov/pubmed/26653538
http://dx.doi.org/10.1021/acs.jproteome.5b00859

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4779376/
https://www.ncbi.nlm.nih.gov/pubmed/26653538
http://dx.doi.org/10.1021/acs.jproteome.5b00859

Ejemplares similares